Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
92M
-
Shares change
-
+9.36M
-
Total reported value, excl. options
-
$1.55B
-
Value change
-
+$162M
-
Put/Call ratio
-
0.28
-
Number of buys
-
104
-
Number of sells
-
-63
-
Price
-
$16.84
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q3 2024
191 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q3 2024.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92M shares
of 240M outstanding shares and own 38.29% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (11.7M shares), FMR LLC (5.62M shares), MORGAN STANLEY (5.38M shares), ACADIAN ASSET MANAGEMENT LLC (4.39M shares), Nine Ten Capital Management LLC (4.33M shares), Clal Insurance Enterprises Holdings Ltd (3.97M shares), CROSSLINK CAPITAL INC (3.49M shares), Voss Capital, LP (3.2M shares), Pertento Partners LLP (2.35M shares), and Phoenix Financial Ltd. (2.27M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.